Ironwood Pharmaceuticals, Inc. (IRWD)
3.46
-0.11
(-3.08%)
USD |
NASDAQ |
Oct 23, 16:00
3.455
0.00 (0.00%)
After-Hours: 20:00
Ironwood Pharmaceuticals Market Cap : 571.73M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 571.73M |
| October 22, 2026 | 589.91M |
| October 21, 2026 | 586.60M |
| October 20, 2026 | 599.82M |
| October 19, 2026 | 588.25M |
| October 16, 2026 | 578.34M |
| October 15, 2026 | 622.95M |
| October 14, 2026 | 594.86M |
| October 13, 2026 | 593.21M |
| October 12, 2026 | 621.30M |
| October 09, 2026 | 631.22M |
| October 08, 2026 | 639.48M |
| October 07, 2026 | 619.65M |
| October 06, 2026 | 599.82M |
| October 05, 2026 | 603.13M |
| October 02, 2026 | 601.47M |
| October 01, 2026 | 621.30M |
| September 30, 2026 | 656.00M |
| September 29, 2026 | 687.40M |
| September 28, 2026 | 680.79M |
| September 25, 2026 | 682.44M |
| September 24, 2026 | 692.36M |
| September 23, 2026 | 705.57M |
| September 22, 2026 | 747.71M |
| September 21, 2026 | 728.71M |
| Date | Value |
|---|---|
| September 18, 2026 | 720.45M |
| September 17, 2026 | 698.96M |
| September 16, 2026 | 689.05M |
| September 15, 2026 | 670.87M |
| September 14, 2026 | 689.05M |
| September 11, 2026 | 674.18M |
| September 10, 2026 | 656.00M |
| September 09, 2026 | 672.53M |
| September 08, 2026 | 689.05M |
| September 04, 2026 | 703.92M |
| September 03, 2026 | 708.88M |
| September 02, 2026 | 728.71M |
| September 01, 2026 | 705.57M |
| August 31, 2026 | 702.27M |
| August 28, 2026 | 682.44M |
| August 27, 2026 | 700.62M |
| August 26, 2026 | 708.88M |
| August 25, 2026 | 725.40M |
| August 24, 2026 | 682.44M |
| August 21, 2026 | 708.88M |
| August 20, 2026 | 684.09M |
| August 19, 2026 | 720.45M |
| August 18, 2026 | 712.18M |
| August 17, 2026 | 720.45M |
| August 14, 2026 | 712.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 504.75B |
| Xencor, Inc. | 1.872B |
| Viking Therapeutics, Inc. | 2.846B |
| IDEAYA Biosciences, Inc. | 3.345B |
| BioMarin Pharmaceutical, Inc. | 10.83B |
Market Cap Related Metrics
| PE Ratio | 4.512 |
| PS Ratio | 1.498 |
| Price to Free Cash Flow | 3.142 |
| Price | 3.46 |
| Earnings Yield | 22.16% |
| Operating PE Ratio | 2.470 |
| Normalized PE Ratio | 4.469 |